OCV Partners β Full Portfolio
20 tracked investments Β· listed companies and verified rows first
Therapeutic company focused on validated targets for treating neurological and psychiatric disorders.
BiotechCambridge, US
Kiran Reddy(Executive Officer, Director)
BoardNicholas G. Galakatos(Director)
Co-investorsClarusVida Ventures
Precision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
BiotechDeep TechHealthtechDurham, US
JEFF SMITH(Executive Officer)DEREK JANTZ(Executive Officer, Director)MATTHEW KANE(Executive Officer, Director)Jeff Smith(Co-founder)Derek Jantz(Co-founder)TODD MELBY(Executive Officer)
Co-investorsage1Aliment CapitalBrace PharmaF-Prime CapitalOUP (Osage University Partners)Pontifax AgTech+4 more
SafeBreach offers a continuous threat exposure management (CTEM) platform that combines breach and attack simulation, attack path validation, and an AI agent to help enterprise security teams identify, prioritize, and remediate cyber risk.
AI & Machine LearningCybersecurityEnterprise SoftwareSaaS
Guy Bejerano(CEO & Co-founder)inItzik Kotler(CTO & Co-founder)inMichal Weiner(Chief Financial Officer)inRaman Kumar(Chief Customer Officer)
Co-investorsBain CapitalDTCP33NBright Pixel CapitalDnx VenturesEmerald Development Managers+2 more
ByHeart is an infant formula company navigating an FDA return-to-market process following a product outbreak investigation.
ConsumerDirect to ConsumerFoodTechHealthtechNew York, US
Mia B. Funt(Executive Officer, Director)Ron Belldegrun(Executive Officer, Director, Promoter)Mia Funt(Founder)inGeorg Krause-Vilmar(Executive Officer)Niall Mullane(Executive Officer)
BoardAmy Schulman(Director)in
Board seatHemi ZuckerΒ· per SEC Form D
Co-investorsEvolution VC PartnersPolaris PartnersRed Sea VenturesVida Ventures
HealthtechNew York, US
Ron Belldegrun(Executive Officer, Director)Georg Krause-Vilmar(Executive Officer)Mia B. Funt(Executive Officer, Director)Devon Kuehn(Executive Officer)Niall Mullane(Executive Officer)Neil Betteridge(Executive Officer)
Board seatHemi ZuckerΒ· per SEC Form D Β· $20.3M raise Β· filed Jul 2026
Co-investorsVida Ventures
Develops novel oncology therapeutics using breakthrough medicinal chemistry technology and biomarker-driven assays to accelerate drug discovery and clinical approval timelines.
Culver City, US
Brian Stoltz(Director)Mark Attanasio(Director)David Chang(Director)David Licata(Director)Dennis Slamon(Director)
Co-investorsKairos Venture Investments, Llc
Museum of Ice Cream operates interactive, ice cream-themed attractions featuring immersive rooms, a sprinkle pool, novelty desserts, cocktails, and retail products.
ConsumerMedia & Entertainment
Co-investorsElizabeth Street VenturesMaywic Select Investments
Figure 8 is an experience-first company that designs and builds immersive physical spaces ("experiums") intended to bring people together and connect them with themselves, each other, and their surroundings.
ConsumerMedia & Entertainment
Finch Therapeutics is a life sciences company focused on the development and protection of drug-related intellectual property and therapeutics within the biotechnology and pharmaceutical industry.
BiotechHealthtechMedical DevicesSomerville, US
Mark Smith(Executive Officer, Director)Matt Blischak(Chief Executive Officer)R. J. Price(Director)Jeffery A. Smisek(Director)Andrew Mulderry(Director)James Burgess(Director)
Co-investorsB3 HoldingOctave Ventures LlcOMX VenturesShumway CapitalHumboldt
Subscription-based mobile app helping small business owners win jobs, track payments, and manage client payment options.
Co-investorsAccelRibbit Capital
Data-driven legal technology platform providing an end-to-end solution combining technology, funding, and expertise to efficiently resolve civil cases.
Ockam is an open-source library that enables developers to build secure communication channels with end-to-end encryption and mutual authentication across any network, cloud, or on-premises infrastructure.
CybersecurityDeveloper ToolsSan Francisco, US
Matthew Gregory(Founder)
Co-investorsAspect VenturesCore Ventures GroupSGH CapitalSINEWAVE VENTURESFuture Ventures
Social Native (at olapic.com) offers an AI-powered creator marketing platform trained on 1.8M+ creator collaborations and $8B in paid media, predicting brief, creator, and platform performance before spend.
AI & Machine LearningCreator EconomyE-commerceMarketing TechSocialNew York, US
David Shadpour(Founder & CEO)Eytan Elbaz(Co-Founder)inJose De Cabo(Executive Officer, Director)Luis Sanz Arilla(Executive Officer, Director)
BoardBen Lin(Director)
Co-investorsAct One VenturesContour Venture PartnersFELIX CAPITALScout VenturesScout VenturesLongworth Venture Partners+2 more
Orca AI applies computer vision and deep learning to maritime shipping, providing situational awareness and automation tools to help commercial vessels navigate more safely and operate more efficiently.
AI & Machine LearningDeep TechLogistics & Supply ChainMobility & Transportation
Yarden Gross(Co-founder & CEO)inDor Raviv(Co-founder & CTO)inShoval Bolotin(VP Product / Operations)inFabrizio Ferraro(Global Sales Lead)inLirit(CFO)inAmit(VP R&D)in
Co-investorsAnkona CapitalBrighton Park CapitalMizMaa VenturestheDOCKSanta Barbara Venture Partners
OSSIO develops OSSIOfiber, a bio-integrative bone fixation implant material made from natural mineral fibers that provides stability during healing and integrates fully into bone over 18-24 months, avoiding permanent metal hardware.
BiotechHealthtechMedical DevicesNew MaterialsPalmetto, US
Orahn Preiss-Bloom(Founder & Chief Innovation Officer)Brian Verrier(Chief Executive Officer)Brennan Marilla(Chief Commercial and Operating Officer)Moshe Shneor(Chief Financial Officer)Gregory C. Berlet(Chief Medical Officer)
Co-investorsQuesta CapitalSecocha Ventures
Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.
BiotechDeep TechHealthtech
Co-investorsAvoro Capital AdvisorsCapria VenturesAlameda ResearchNorwest Venture Partners
Rad AI develops generative AI models and automation solutions specifically designed for radiology and healthcare workflows.
AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSan Francisco, US
Dr. Jeff Chang(Co-founder)inDoktor Gurson(Co-founder)in
BoardStuart Peterson(Director)inBruce Armstrong(Director)in
PartnerChris BostickΒ· led
Co-investorsAlpha PartnersArray Ventures Management LlcArtis VenturesCity LightCorewell Health VenturesFifty Years+9 more
Social Native runs an AI-powered creator marketing platform that matches brands with content creators, predicts campaign performance, and manages briefs-to-payout, drawing on data from 1.8M+ creator collaborations and $8B in paid media.
AI & Machine LearningCreator EconomyMarketing TechBeverly Hills, US
David Shadpour(Founder)inJordan Levy(Director)
Co-investorsMiramar Venture PartnersTenOneTen Ventures
Online subscription fashion retailer carrying shoes, handbags, jewelry, and denim through brands including Fabletics, Justfab, ShoeDazzle, and Savage x Fenty.
Co-investorsCrosscut VenturesManhattan WestL CattertonNeuberger BermanSugar Capital
Clinical-stage biotechnology company developing novel antibody-based therapies to transform cancer treatment.
BiotechCulver City, US
Mark Alles(Executive Officer, Director)Mark Attanasio(Director)David Licata(Executive Officer, Director)Neil O'Brien(Director)Amit Sinha(Director)Lynn Seely(Director)
PartnerChris BostickΒ· led
Co-investorsCowen Healthcare InvestmentsGoldman SachsPerceptive Xontogeny VentureVertex Ventures HC
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.





